nodes	percent_of_prediction	percent_of_DWPC	metapath
Clevidipine—BCHE—multiple sclerosis	0.495	1	CbGaD
Clevidipine—CYP2E1—Fingolimod—multiple sclerosis	0.0876	0.199	CbGbCtD
Clevidipine—BCHE—Triamcinolone—multiple sclerosis	0.0852	0.193	CbGbCtD
Clevidipine—CYP2D6—Fingolimod—multiple sclerosis	0.0417	0.0946	CbGbCtD
Clevidipine—CYP2E1—Mitoxantrone—multiple sclerosis	0.0412	0.0933	CbGbCtD
Clevidipine—CYP3A4—Fingolimod—multiple sclerosis	0.0265	0.0602	CbGbCtD
Clevidipine—CYP2C19—Prednisone—multiple sclerosis	0.0214	0.0486	CbGbCtD
Clevidipine—CYP2E1—Dexamethasone—multiple sclerosis	0.0213	0.0484	CbGbCtD
Clevidipine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0171	0.0388	CbGbCtD
Clevidipine—CYP2C19—Dexamethasone—multiple sclerosis	0.0134	0.0303	CbGbCtD
Clevidipine—CYP3A4—Triamcinolone—multiple sclerosis	0.013	0.0294	CbGbCtD
Clevidipine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0125	0.0283	CbGbCtD
Clevidipine—CYP2C9—Dexamethasone—multiple sclerosis	0.0111	0.0252	CbGbCtD
Clevidipine—CYP3A4—Betamethasone—multiple sclerosis	0.0111	0.0252	CbGbCtD
Clevidipine—CYP3A4—Prednisolone—multiple sclerosis	0.011	0.0249	CbGbCtD
Clevidipine—CYP3A4—Prednisone—multiple sclerosis	0.0104	0.0235	CbGbCtD
Clevidipine—CYP2D6—Dexamethasone—multiple sclerosis	0.0102	0.0231	CbGbCtD
Clevidipine—CYP3A4—Dexamethasone—multiple sclerosis	0.00647	0.0147	CbGbCtD
Clevidipine—Blood triglycerides increased—Fingolimod—multiple sclerosis	0.00341	0.128	CcSEcCtD
Clevidipine—Ileus—Cladribine—multiple sclerosis	0.00179	0.0673	CcSEcCtD
Clevidipine—Renal failure acute—Cladribine—multiple sclerosis	0.000996	0.0375	CcSEcCtD
Clevidipine—Atrial fibrillation—Cladribine—multiple sclerosis	0.00097	0.0365	CcSEcCtD
Clevidipine—Blood triglycerides increased—Prednisone—multiple sclerosis	0.000758	0.0285	CcSEcCtD
Clevidipine—Hypotension—Fingolimod—multiple sclerosis	0.000745	0.028	CcSEcCtD
Clevidipine—Dyspnoea—Fingolimod—multiple sclerosis	0.000711	0.0267	CcSEcCtD
Clevidipine—Renal failure acute—Mitoxantrone—multiple sclerosis	0.000655	0.0246	CcSEcCtD
Clevidipine—Headache—Fingolimod—multiple sclerosis	0.000499	0.0188	CcSEcCtD
Clevidipine—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.000459	0.0173	CcSEcCtD
Clevidipine—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.000457	0.0172	CcSEcCtD
Clevidipine—Tachycardia—Cladribine—multiple sclerosis	0.000441	0.0166	CcSEcCtD
Clevidipine—Hypotension—Cladribine—multiple sclerosis	0.000422	0.0159	CcSEcCtD
Clevidipine—Dyspnoea—Cladribine—multiple sclerosis	0.000403	0.0152	CcSEcCtD
Clevidipine—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000377	0.0142	CcSEcCtD
Clevidipine—Myocardial infarction—Prednisolone—multiple sclerosis	0.000375	0.0141	CcSEcCtD
Clevidipine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000346	0.013	CcSEcCtD
Clevidipine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000346	0.013	CcSEcCtD
Clevidipine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000344	0.013	CcSEcCtD
Clevidipine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000344	0.0129	CcSEcCtD
Clevidipine—Hypotension—Azathioprine—multiple sclerosis	0.000343	0.0129	CcSEcCtD
Clevidipine—Hypersensitivity—Cladribine—multiple sclerosis	0.000333	0.0125	CcSEcCtD
Clevidipine—Renal failure acute—Methotrexate—multiple sclerosis	0.000326	0.0123	CcSEcCtD
Clevidipine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000314	0.0118	CcSEcCtD
Clevidipine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000314	0.0118	CcSEcCtD
Clevidipine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000313	0.0118	CcSEcCtD
Clevidipine—Myocardial infarction—Betamethasone—multiple sclerosis	0.000313	0.0118	CcSEcCtD
Clevidipine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00029	0.0109	CcSEcCtD
Clevidipine—Vomiting—Cladribine—multiple sclerosis	0.000287	0.0108	CcSEcCtD
Clevidipine—Headache—Cladribine—multiple sclerosis	0.000283	0.0107	CcSEcCtD
Clevidipine—Hypotension—Mitoxantrone—multiple sclerosis	0.000278	0.0104	CcSEcCtD
Clevidipine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000274	0.0103	CcSEcCtD
Clevidipine—Myocardial infarction—Prednisone—multiple sclerosis	0.000272	0.0102	CcSEcCtD
Clevidipine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000271	0.0102	CcSEcCtD
Clevidipine—Nausea—Cladribine—multiple sclerosis	0.000268	0.0101	CcSEcCtD
Clevidipine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000265	0.00996	CcSEcCtD
Clevidipine—Tachycardia—Prednisolone—multiple sclerosis	0.000238	0.00895	CcSEcCtD
Clevidipine—Vomiting—Azathioprine—multiple sclerosis	0.000234	0.00879	CcSEcCtD
Clevidipine—Headache—Azathioprine—multiple sclerosis	0.00023	0.00866	CcSEcCtD
Clevidipine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000219	0.00823	CcSEcCtD
Clevidipine—Tachycardia—Triamcinolone—multiple sclerosis	0.000219	0.00823	CcSEcCtD
Clevidipine—Nausea—Azathioprine—multiple sclerosis	0.000218	0.00821	CcSEcCtD
Clevidipine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000218	0.00821	CcSEcCtD
Clevidipine—Hypotension—Methylprednisolone—multiple sclerosis	0.000209	0.00786	CcSEcCtD
Clevidipine—Dyspnoea—Triamcinolone—multiple sclerosis	0.0002	0.00752	CcSEcCtD
Clevidipine—Tachycardia—Betamethasone—multiple sclerosis	0.000198	0.00747	CcSEcCtD
Clevidipine—Tachycardia—Dexamethasone—multiple sclerosis	0.000198	0.00747	CcSEcCtD
Clevidipine—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000193	0.00525	CbGpPWpGaD
Clevidipine—CACNA1S—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000192	0.00521	CbGpPWpGaD
Clevidipine—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000191	0.0052	CbGpPWpGaD
Clevidipine—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000191	0.0052	CbGpPWpGaD
Clevidipine—Hypotension—Dexamethasone—multiple sclerosis	0.00019	0.00715	CcSEcCtD
Clevidipine—Hypotension—Betamethasone—multiple sclerosis	0.00019	0.00715	CcSEcCtD
Clevidipine—Vomiting—Mitoxantrone—multiple sclerosis	0.000189	0.00711	CcSEcCtD
Clevidipine—Headache—Mitoxantrone—multiple sclerosis	0.000186	0.007	CcSEcCtD
Clevidipine—CACNA1D—Alzheimers Disease—APOE—multiple sclerosis	0.000181	0.00492	CbGpPWpGaD
Clevidipine—Hypersensitivity—Prednisolone—multiple sclerosis	0.00018	0.00675	CcSEcCtD
Clevidipine—Nausea—Mitoxantrone—multiple sclerosis	0.000176	0.00664	CcSEcCtD
Clevidipine—CACNA1C—Alzheimers Disease—FAS—multiple sclerosis	0.000173	0.00471	CbGpPWpGaD
Clevidipine—Tachycardia—Prednisone—multiple sclerosis	0.000173	0.0065	CcSEcCtD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000173	0.0047	CbGpPWpGaD
Clevidipine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000173	0.0047	CbGpPWpGaD
Clevidipine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000165	0.00621	CcSEcCtD
Clevidipine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000165	0.0062	CcSEcCtD
Clevidipine—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000163	0.00445	CbGpPWpGaD
Clevidipine—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000163	0.00445	CbGpPWpGaD
Clevidipine—CACNA1C—Alzheimers Disease—APOE—multiple sclerosis	0.000159	0.00432	CbGpPWpGaD
Clevidipine—CACNA1S—Axon guidance—PRNP—multiple sclerosis	0.000158	0.0043	CbGpPWpGaD
Clevidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000156	0.00423	CbGpPWpGaD
Clevidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000156	0.00423	CbGpPWpGaD
Clevidipine—CACNA1D—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000156	0.00423	CbGpPWpGaD
Clevidipine—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000153	0.00418	CbGpPWpGaD
Clevidipine—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000153	0.00418	CbGpPWpGaD
Clevidipine—Headache—Prednisolone—multiple sclerosis	0.000153	0.00574	CcSEcCtD
Clevidipine—Nausea—Prednisolone—multiple sclerosis	0.000145	0.00545	CcSEcCtD
Clevidipine—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000144	0.00393	CbGpPWpGaD
Clevidipine—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000144	0.00393	CbGpPWpGaD
Clevidipine—Vomiting—Triamcinolone—multiple sclerosis	0.000142	0.00536	CcSEcCtD
Clevidipine—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000142	0.00388	CbGpPWpGaD
Clevidipine—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000142	0.00388	CbGpPWpGaD
Clevidipine—Vomiting—Methylprednisolone—multiple sclerosis	0.000142	0.00535	CcSEcCtD
Clevidipine—CACNA1S—Alzheimers Disease—IL1B—multiple sclerosis	0.000142	0.00386	CbGpPWpGaD
Clevidipine—Headache—Triamcinolone—multiple sclerosis	0.00014	0.00528	CcSEcCtD
Clevidipine—Headache—Methylprednisolone—multiple sclerosis	0.00014	0.00527	CcSEcCtD
Clevidipine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.00014	0.0038	CbGpPWpGaD
Clevidipine—Hypotension—Methotrexate—multiple sclerosis	0.000138	0.0052	CcSEcCtD
Clevidipine—CACNA1C—NCAM signaling for neurite out-growth—TYK2—multiple sclerosis	0.000137	0.00372	CbGpPWpGaD
Clevidipine—Nausea—Triamcinolone—multiple sclerosis	0.000133	0.00501	CcSEcCtD
Clevidipine—Nausea—Methylprednisolone—multiple sclerosis	0.000133	0.005	CcSEcCtD
Clevidipine—Dyspnoea—Methotrexate—multiple sclerosis	0.000132	0.00496	CcSEcCtD
Clevidipine—Hypersensitivity—Prednisone—multiple sclerosis	0.00013	0.00491	CcSEcCtD
Clevidipine—Vomiting—Betamethasone—multiple sclerosis	0.000129	0.00486	CcSEcCtD
Clevidipine—Vomiting—Dexamethasone—multiple sclerosis	0.000129	0.00486	CcSEcCtD
Clevidipine—CACNA1D—Axon guidance—PRNP—multiple sclerosis	0.000128	0.00349	CbGpPWpGaD
Clevidipine—Headache—Betamethasone—multiple sclerosis	0.000127	0.00479	CcSEcCtD
Clevidipine—Headache—Dexamethasone—multiple sclerosis	0.000127	0.00479	CcSEcCtD
Clevidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000126	0.00343	CbGpPWpGaD
Clevidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000126	0.00343	CbGpPWpGaD
Clevidipine—CACNA1S—Axon guidance—PTPRC—multiple sclerosis	0.000123	0.00334	CbGpPWpGaD
Clevidipine—CACNA1S—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	0.000122	0.00332	CbGpPWpGaD
Clevidipine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000122	0.00331	CbGpPWpGaD
Clevidipine—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000121	0.0033	CbGpPWpGaD
Clevidipine—Nausea—Dexamethasone—multiple sclerosis	0.000121	0.00454	CcSEcCtD
Clevidipine—Nausea—Betamethasone—multiple sclerosis	0.000121	0.00454	CcSEcCtD
Clevidipine—CACNA1D—Alzheimers Disease—IL1B—multiple sclerosis	0.000115	0.00314	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—PRNP—multiple sclerosis	0.000113	0.00307	CbGpPWpGaD
Clevidipine—CACNA1C—Axon guidance—PRNP—multiple sclerosis	0.000113	0.00307	CbGpPWpGaD
Clevidipine—Vomiting—Prednisone—multiple sclerosis	0.000113	0.00424	CcSEcCtD
Clevidipine—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000111	0.00303	CbGpPWpGaD
Clevidipine—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000111	0.00303	CbGpPWpGaD
Clevidipine—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000111	0.00303	CbGpPWpGaD
Clevidipine—Headache—Prednisone—multiple sclerosis	0.000111	0.00417	CcSEcCtD
Clevidipine—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00011	0.00299	CbGpPWpGaD
Clevidipine—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00011	0.00299	CbGpPWpGaD
Clevidipine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000109	0.0041	CcSEcCtD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000108	0.00295	CbGpPWpGaD
Clevidipine—CACNA1S—Alzheimers Disease—MAPK1—multiple sclerosis	0.000108	0.00294	CbGpPWpGaD
Clevidipine—Nausea—Prednisone—multiple sclerosis	0.000105	0.00396	CcSEcCtD
Clevidipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000104	0.00283	CbGpPWpGaD
Clevidipine—CACNA1S—Alzheimers Disease—TNF—multiple sclerosis	0.000103	0.0028	CbGpPWpGaD
Clevidipine—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000102	0.00279	CbGpPWpGaD
Clevidipine—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000102	0.00279	CbGpPWpGaD
Clevidipine—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000102	0.00276	CbGpPWpGaD
Clevidipine—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000102	0.00276	CbGpPWpGaD
Clevidipine—CACNA1C—Alzheimers Disease—IL1B—multiple sclerosis	0.000101	0.00276	CbGpPWpGaD
Clevidipine—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000101	0.00275	CbGpPWpGaD
Clevidipine—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000101	0.00275	CbGpPWpGaD
Clevidipine—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.0001	0.00273	CbGpPWpGaD
Clevidipine—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.0001	0.00273	CbGpPWpGaD
Clevidipine—CACNA1D—Axon guidance—PTPRC—multiple sclerosis	9.97e-05	0.00271	CbGpPWpGaD
Clevidipine—CACNA1D—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	9.9e-05	0.00269	CbGpPWpGaD
Clevidipine—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	9.59e-05	0.00261	CbGpPWpGaD
Clevidipine—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	9.44e-05	0.00257	CbGpPWpGaD
Clevidipine—Vomiting—Methotrexate—multiple sclerosis	9.41e-05	0.00354	CcSEcCtD
Clevidipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	9.37e-05	0.00255	CbGpPWpGaD
Clevidipine—Headache—Methotrexate—multiple sclerosis	9.27e-05	0.00349	CcSEcCtD
Clevidipine—CACNA1D—Developmental Biology—PRNP—multiple sclerosis	9.15e-05	0.00249	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—SRM—multiple sclerosis	8.99e-05	0.00245	CbGpPWpGaD
Clevidipine—BCHE—Peptide hormone metabolism—POMC—multiple sclerosis	8.81e-05	0.0024	CbGpPWpGaD
Clevidipine—Nausea—Methotrexate—multiple sclerosis	8.79e-05	0.00331	CcSEcCtD
Clevidipine—CACNA1D—Alzheimers Disease—MAPK1—multiple sclerosis	8.78e-05	0.00239	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—PTPRC—multiple sclerosis	8.76e-05	0.00238	CbGpPWpGaD
Clevidipine—CACNA1C—Axon guidance—PTPRC—multiple sclerosis	8.76e-05	0.00238	CbGpPWpGaD
Clevidipine—CACNA1C—NCAM signaling for neurite out-growth—MAPK1—multiple sclerosis	8.7e-05	0.00237	CbGpPWpGaD
Clevidipine—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	8.68e-05	0.00236	CbGpPWpGaD
Clevidipine—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	8.68e-05	0.00236	CbGpPWpGaD
Clevidipine—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.56e-05	0.00233	CbGpPWpGaD
Clevidipine—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.56e-05	0.00233	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.56e-05	0.00233	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.56e-05	0.00233	CbGpPWpGaD
Clevidipine—CACNA1D—Alzheimers Disease—TNF—multiple sclerosis	8.36e-05	0.00228	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—PRNP—multiple sclerosis	8.04e-05	0.00219	CbGpPWpGaD
Clevidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.02e-05	0.00218	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—SRM—multiple sclerosis	7.9e-05	0.00215	CbGpPWpGaD
Clevidipine—CACNA1C—Alzheimers Disease—MAPK1—multiple sclerosis	7.72e-05	0.0021	CbGpPWpGaD
Clevidipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	7.61e-05	0.00207	CbGpPWpGaD
Clevidipine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.54e-05	0.00205	CbGpPWpGaD
Clevidipine—CACNA1C—Alzheimers Disease—TNF—multiple sclerosis	7.35e-05	0.002	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—PTPRC—multiple sclerosis	7.11e-05	0.00194	CbGpPWpGaD
Clevidipine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.7e-05	0.00182	CbGpPWpGaD
Clevidipine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.7e-05	0.00182	CbGpPWpGaD
Clevidipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—multiple sclerosis	6.68e-05	0.00182	CbGpPWpGaD
Clevidipine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	6.61e-05	0.0018	CbGpPWpGaD
Clevidipine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	6.61e-05	0.0018	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—CYP24A1—multiple sclerosis	6.33e-05	0.00172	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—CYP27B1—multiple sclerosis	6.33e-05	0.00172	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—PTPRC—multiple sclerosis	6.25e-05	0.0017	CbGpPWpGaD
Clevidipine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.11e-05	0.00166	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of proteins—SLC30A7—multiple sclerosis	6.03e-05	0.00164	CbGpPWpGaD
Clevidipine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.82e-05	0.00158	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—GPC5—multiple sclerosis	5.79e-05	0.00158	CbGpPWpGaD
Clevidipine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	5.57e-05	0.00152	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—CYP24A1—multiple sclerosis	5.57e-05	0.00151	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—CYP27B1—multiple sclerosis	5.57e-05	0.00151	CbGpPWpGaD
Clevidipine—CACNA1S—Axon guidance—TYK2—multiple sclerosis	5.49e-05	0.0015	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—SRM—multiple sclerosis	5.41e-05	0.00147	CbGpPWpGaD
Clevidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.35e-05	0.00146	CbGpPWpGaD
Clevidipine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.3e-05	0.00144	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—GPC5—multiple sclerosis	5.09e-05	0.00139	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of proteins—PABPC1—multiple sclerosis	4.87e-05	0.00133	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—RRM1—multiple sclerosis	4.8e-05	0.00131	CbGpPWpGaD
Clevidipine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.72e-05	0.00128	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	4.66e-05	0.00127	CbGpPWpGaD
Clevidipine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.53e-05	0.00123	CbGpPWpGaD
Clevidipine—CACNA1D—Axon guidance—TYK2—multiple sclerosis	4.46e-05	0.00121	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of proteins—RPL5—multiple sclerosis	4.4e-05	0.0012	CbGpPWpGaD
Clevidipine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.34e-05	0.00118	CbGpPWpGaD
Clevidipine—CACNA1S—Axon guidance—MMP9—multiple sclerosis	4.33e-05	0.00118	CbGpPWpGaD
Clevidipine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.3e-05	0.00117	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.28e-05	0.00116	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.28e-05	0.00116	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—RRM1—multiple sclerosis	4.22e-05	0.00115	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	4.16e-05	0.00113	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	4.15e-05	0.00113	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—TYK2—multiple sclerosis	3.92e-05	0.00107	CbGpPWpGaD
Clevidipine—CACNA1C—Axon guidance—TYK2—multiple sclerosis	3.92e-05	0.00107	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.9e-05	0.00106	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.9e-05	0.00106	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—CYP24A1—multiple sclerosis	3.81e-05	0.00104	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—CYP27B1—multiple sclerosis	3.81e-05	0.00104	CbGpPWpGaD
Clevidipine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.68e-05	0.001	CbGpPWpGaD
Clevidipine—CACNA1D—Axon guidance—MMP9—multiple sclerosis	3.51e-05	0.000956	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—SRM—multiple sclerosis	3.5e-05	0.000954	CbGpPWpGaD
Clevidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.5e-05	0.000952	CbGpPWpGaD
Clevidipine—CACNA1S—Axon guidance—MAPK1—multiple sclerosis	3.5e-05	0.000952	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—GPC5—multiple sclerosis	3.48e-05	0.000949	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.33e-05	0.000907	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.33e-05	0.000907	CbGpPWpGaD
Clevidipine—CYP2E1—Biological oxidations—POMC—multiple sclerosis	3.25e-05	0.000884	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	3.24e-05	0.000882	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	3.23e-05	0.00088	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—TYK2—multiple sclerosis	3.18e-05	0.000866	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	3.17e-05	0.000863	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—MMP9—multiple sclerosis	3.09e-05	0.00084	CbGpPWpGaD
Clevidipine—CACNA1C—Axon guidance—MMP9—multiple sclerosis	3.09e-05	0.00084	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	3.02e-05	0.000822	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	3.02e-05	0.000822	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—RRM1—multiple sclerosis	2.89e-05	0.000786	CbGpPWpGaD
Clevidipine—CACNA1D—Axon guidance—MAPK1—multiple sclerosis	2.84e-05	0.000773	CbGpPWpGaD
Clevidipine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.84e-05	0.000772	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—TYK2—multiple sclerosis	2.8e-05	0.000761	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—BCHE—multiple sclerosis	2.76e-05	0.00075	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—STAT3—multiple sclerosis	2.75e-05	0.000747	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—SRM—multiple sclerosis	2.7e-05	0.000736	CbGpPWpGaD
Clevidipine—CACNA1S—Axon guidance—IL6—multiple sclerosis	2.69e-05	0.000731	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—TGFB1—multiple sclerosis	2.54e-05	0.000693	CbGpPWpGaD
Clevidipine—BCHE—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.51e-05	0.000684	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—MMP9—multiple sclerosis	2.51e-05	0.000682	CbGpPWpGaD
Clevidipine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.51e-05	0.000682	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—MAPK1—multiple sclerosis	2.5e-05	0.000679	CbGpPWpGaD
Clevidipine—CACNA1C—Axon guidance—MAPK1—multiple sclerosis	2.49e-05	0.000679	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—SRM—multiple sclerosis	2.49e-05	0.000677	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2.47e-05	0.000672	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2.47e-05	0.000672	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—SRM—multiple sclerosis	2.46e-05	0.000671	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—BCHE—multiple sclerosis	2.42e-05	0.000659	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—TNF—multiple sclerosis	2.38e-05	0.000647	CbGpPWpGaD
Clevidipine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.3e-05	0.000627	CbGpPWpGaD
Clevidipine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.28e-05	0.000622	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.26e-05	0.000615	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.24e-05	0.00061	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—STAT3—multiple sclerosis	2.23e-05	0.000607	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—MMP9—multiple sclerosis	2.2e-05	0.000599	CbGpPWpGaD
Clevidipine—CACNA1D—Axon guidance—IL6—multiple sclerosis	2.18e-05	0.000594	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—SRM—multiple sclerosis	2.11e-05	0.000573	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—TGFB1—multiple sclerosis	2.07e-05	0.000562	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—MAPK1—multiple sclerosis	2.03e-05	0.000551	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—STAT3—multiple sclerosis	1.96e-05	0.000533	CbGpPWpGaD
Clevidipine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.95e-05	0.000531	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—TNF—multiple sclerosis	1.93e-05	0.000525	CbGpPWpGaD
Clevidipine—BCHE—Neuronal System—MAPK1—multiple sclerosis	1.92e-05	0.000524	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.92e-05	0.000524	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—IL6—multiple sclerosis	1.92e-05	0.000522	CbGpPWpGaD
Clevidipine—CACNA1C—Axon guidance—IL6—multiple sclerosis	1.92e-05	0.000522	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.9e-05	0.000518	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.9e-05	0.000518	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.87e-05	0.000509	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.86e-05	0.000507	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—TGFB1—multiple sclerosis	1.82e-05	0.000494	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—MAPK1—multiple sclerosis	1.78e-05	0.000485	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.75e-05	0.000478	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.75e-05	0.000477	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.75e-05	0.000477	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.74e-05	0.000474	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.74e-05	0.000473	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.74e-05	0.000473	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.7e-05	0.000462	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—TNF—multiple sclerosis	1.7e-05	0.000461	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of proteins—POMC—multiple sclerosis	1.66e-05	0.000453	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—APOE—multiple sclerosis	1.66e-05	0.000451	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of proteins—CCL2—multiple sclerosis	1.63e-05	0.000443	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.63e-05	0.000442	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.6e-05	0.000436	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.59e-05	0.000432	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—IL6—multiple sclerosis	1.56e-05	0.000424	CbGpPWpGaD
Clevidipine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.51e-05	0.00041	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.48e-05	0.000404	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.48e-05	0.000404	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—APOE—multiple sclerosis	1.46e-05	0.000397	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.45e-05	0.000395	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.44e-05	0.000393	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—POMC—multiple sclerosis	1.42e-05	0.000388	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—IL6—multiple sclerosis	1.37e-05	0.000372	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.36e-05	0.000369	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.33e-05	0.000361	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.32e-05	0.000358	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—ALB—multiple sclerosis	1.3e-05	0.000354	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—POMC—multiple sclerosis	1.25e-05	0.000341	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.15e-05	0.000312	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.15e-05	0.000312	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—ALB—multiple sclerosis	1.14e-05	0.000311	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.12e-05	0.000306	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.12e-05	0.000305	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.07e-05	0.000292	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.05e-05	0.000285	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.02e-05	0.000278	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—APOE—multiple sclerosis	9.98e-06	0.000272	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.62e-06	0.000262	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.77e-06	0.000239	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.77e-06	0.000239	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.73e-06	0.000238	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—RRM1—multiple sclerosis	8.68e-06	0.000236	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—POMC—multiple sclerosis	8.57e-06	0.000233	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—BCHE—multiple sclerosis	8.29e-06	0.000226	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8e-06	0.000218	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—ALB—multiple sclerosis	7.81e-06	0.000213	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—BCHE—multiple sclerosis	7.63e-06	0.000208	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—BCHE—multiple sclerosis	7.56e-06	0.000206	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.5e-06	0.000204	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.83e-06	0.000186	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—APOE—multiple sclerosis	6.46e-06	0.000176	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.46e-06	0.000176	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—POMC—multiple sclerosis	5.55e-06	0.000151	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—ALB—multiple sclerosis	5.06e-06	0.000138	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—APOE—multiple sclerosis	4.99e-06	0.000136	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.99e-06	0.000136	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—APOE—multiple sclerosis	4.59e-06	0.000125	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—APOE—multiple sclerosis	4.55e-06	0.000124	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—POMC—multiple sclerosis	4.28e-06	0.000117	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—POMC—multiple sclerosis	3.94e-06	0.000107	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—POMC—multiple sclerosis	3.91e-06	0.000106	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—ALB—multiple sclerosis	3.91e-06	0.000106	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—APOE—multiple sclerosis	3.89e-06	0.000106	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—ALB—multiple sclerosis	3.59e-06	9.78e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—ALB—multiple sclerosis	3.56e-06	9.69e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—POMC—multiple sclerosis	3.34e-06	9.09e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ALB—multiple sclerosis	3.04e-06	8.28e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—APOE—multiple sclerosis	3e-06	8.16e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—POMC—multiple sclerosis	2.58e-06	7.01e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.35e-06	6.39e-05	CbGpPWpGaD
